With increasing requests from healthcare professionals and patients globally for access to drugs that are still in clinical development or …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

